Annals on Call
In this episode of Annals On Call, Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
CME/MOC:
Up to 1
AMA PRA Category 1 Credits ™ and MOC Points
Expires August 05, 2028
active
Cost:
Free to Members
Format:
Podcasts and Audio Content
Product:
Annals on Call
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
